Cargando…
Gynecomastia – evaluation and current treatment options
CLINICAL QUESTION: What is the best management approach for gynecomastia? RESULTS: In most patients, surgical correction usually leads to immediate cosmetic and symptomatic improvement and is considered the best approach. In men who are being treated with antiandrogen therapies, pharmacological inte...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071351/ https://www.ncbi.nlm.nih.gov/pubmed/21479145 http://dx.doi.org/10.2147/TCRM.S10181 |
_version_ | 1782201442451324928 |
---|---|
author | Johnson, Ruth E Kermott, Cindy A Murad, M Hassan |
author_facet | Johnson, Ruth E Kermott, Cindy A Murad, M Hassan |
author_sort | Johnson, Ruth E |
collection | PubMed |
description | CLINICAL QUESTION: What is the best management approach for gynecomastia? RESULTS: In most patients, surgical correction usually leads to immediate cosmetic and symptomatic improvement and is considered the best approach. In men who are being treated with antiandrogen therapies, pharmacological intervention with tamoxifen is the most effective approach, followed by radiotherapy. IMPLEMENTATION: : Failure to detect the very rare male breast cancer. Overly aggressive early intervention or evaluation. Appropriate medical intervention. When to refer to specialist treatment; |
format | Text |
id | pubmed-3071351 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-30713512011-04-08 Gynecomastia – evaluation and current treatment options Johnson, Ruth E Kermott, Cindy A Murad, M Hassan Ther Clin Risk Manag Evidence 2 Practice CLINICAL QUESTION: What is the best management approach for gynecomastia? RESULTS: In most patients, surgical correction usually leads to immediate cosmetic and symptomatic improvement and is considered the best approach. In men who are being treated with antiandrogen therapies, pharmacological intervention with tamoxifen is the most effective approach, followed by radiotherapy. IMPLEMENTATION: : Failure to detect the very rare male breast cancer. Overly aggressive early intervention or evaluation. Appropriate medical intervention. When to refer to specialist treatment; Dove Medical Press 2011 2011-03-28 /pmc/articles/PMC3071351/ /pubmed/21479145 http://dx.doi.org/10.2147/TCRM.S10181 Text en © 2011 Johnson et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Evidence 2 Practice Johnson, Ruth E Kermott, Cindy A Murad, M Hassan Gynecomastia – evaluation and current treatment options |
title | Gynecomastia – evaluation and current treatment options |
title_full | Gynecomastia – evaluation and current treatment options |
title_fullStr | Gynecomastia – evaluation and current treatment options |
title_full_unstemmed | Gynecomastia – evaluation and current treatment options |
title_short | Gynecomastia – evaluation and current treatment options |
title_sort | gynecomastia – evaluation and current treatment options |
topic | Evidence 2 Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071351/ https://www.ncbi.nlm.nih.gov/pubmed/21479145 http://dx.doi.org/10.2147/TCRM.S10181 |
work_keys_str_mv | AT johnsonruthe gynecomastiaevaluationandcurrenttreatmentoptions AT kermottcindya gynecomastiaevaluationandcurrenttreatmentoptions AT muradmhassan gynecomastiaevaluationandcurrenttreatmentoptions |